Lexeo Therapeutics, Inc. (LXEO) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $246.67M | +111.1% |
| 2024 | $116.84M | +2.9% |
| 2023 | $113.53M | +200.5% |
| 2022 | -$112.95M | -103.1% |
| 2021 | -$55.60M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $246.67M | +111.1% |
| 2024 | $116.84M | +2.9% |
| 2023 | $113.53M | +200.5% |
| 2022 | -$112.95M | -103.1% |
| 2021 | -$55.60M | — |